Electroporation for Drug and Gene Delivery in the Clinic: Doctors Go Electric

  • Julie Gehl
Part of the Methods in Molecular Biology™ book series (MIMB, volume 423)


Electroporation is a unique system for drug and gene delivery, as it is possible to very specifically target certain tissues within the body with whatever drug, gene, isotope, or other product is desired in a specific situation. An increasing number of clinical trials are being launched, and sophistication of equipment and protocols continues. This chapter reviews present knowledge from clinical trials, describes important issues in the patient management when using electroporation, and outlines future perspectives of the technology.


electroporation clinical protocol electrode electrochemotherapy gene electrotransfer 



The ESOPE study was supported by the European Union's 5th FP, under the leadership of Lluis M. Mir. Dr. Poul F. Geertsen photographed the treatment session shown in Fig. 27.1.


  1. 1.
    1. Jaroszeski, M., Heller, R., and Gilbert, R. (2000) Electrochemotherapy, electrogenetherapy, and transdermal drug delivery. Humana, Totowa, NJ.CrossRefGoogle Scholar
  2. 2.
    2. Belehradek, M., Domenge, C., Luboinski, B., et al. (1993) Electrochemotherapy, a new antitumor treatment. First clinical phase I-II trial. Cancer. 72, 3694–3700.CrossRefPubMedGoogle Scholar
  3. 3.
    3. Gilbert, R.A., Jaroszeski, M.J., and Heller, R. (1997) Novel electrode designs for electrochemotherapy. Biochim. Biophys. Acta. 1334, 9–14.PubMedGoogle Scholar
  4. 4.
    4. Gehl, J., Sørensen, T.H., Nielsen, K., et al. (1999) In vivo electroporation of skeletal muscle: Threshold, efficacy and relation to electric field distribution. Biochim. Biophys. Acta. 1428, 233–240.PubMedGoogle Scholar
  5. 5.
    5. Heller, R., Jaroszeski, M., Atkin, A., et al. (1996) In vivo gene electroinjection and expression in rat liver. FEBS Lett. 389, 225–228.CrossRefPubMedGoogle Scholar
  6. 6.
    6. Bureau, M.F., Gehl, J., Deleuze, V., Mir, L.M., and Scherman, D. (2000) Importance of association between permeabilization and electrophoretic forces for intramuscular DNA electrotransfer. Biochim. Biophys. Acta. 1474, 353–359.PubMedGoogle Scholar
  7. 7.
    7. Mir, L.M., Bureau, M.F., Gehl, J. et al. (1999) High efficiency gene transfer into skeletal muscle mediated by electric pulses. Proc. Natl. Acad. Sci. U.S.A. 96, 4262–4267.CrossRefPubMedGoogle Scholar
  8. 8.
    8. Heller, R., Jaroszeski, M.J., Glass, L.F. et al. (1996) Phase I/II trial for the treatment of cutaneous and subcutaneous tumors using electrochemotherapy. Cancer. 77, 964–971.CrossRefPubMedGoogle Scholar
  9. 9.
    9. Gehl, J. and Geertsen, P. (2000) Efficient palliation of hemorrhaging malignant melanoma skin metastases by electrochemotherapy. Melanoma Res. 10, 585–589.CrossRefPubMedGoogle Scholar
  10. 10.
    10. Marty, M., Sersa, G., Garbay, J.R., Gehl, J., Collins, C.G., Snoj, M., et al. (2006) Electrochemotherapy – An easy, highly effective and safe treatment of cutaneous and subcutaneous metastases: Results of ESOPE (European Standard Operating Procedures of Electrochemotherapy) study. Ejc Supplements. 4, 3–13.Google Scholar
  11. 11.
    11. Aihara, H. and Miyazaki, J.I. (1998) Gene transfer into muscle by electroporation in vivo. Nat. Biotechnol. 16, 867–870.CrossRefPubMedGoogle Scholar
  12. 12.
    12. Mir, L.M., Gehl, J., Sersa, G., Collins, C.G., Garbay, J.R., Billard, V., et al. (2006) Standard operating procedures of the electrochemotherapy: Instructions for the use of bleomycin or cisplantin administered either systemically or locally and electric pulses delivered by the Cliniporator (TM) by means of invasive or non-invasive electrodes. Ejc Supplements. 4, 14–25.Google Scholar
  13. 13.
    13. Gehl, J., Skovsgaard, T., and Mir, L.M. (2002) Vascular reactions to in vivo electroporation: characterization and consequences for drug and gene delivery. Biochim. Biophys. Acta. 1569, 51–58.PubMedGoogle Scholar
  14. 14.
    14. Sersa, G., Cemazar, M., Parkins, C.S., and Chaplin, D.J. (1999) Tumour blood flow changes induced by application of electric pulses. Eur. J. Cancer. 35, 672–677.CrossRefPubMedGoogle Scholar
  15. 15.
    15. Tsurumi, Y., Takeshita, S., Chen, D., et al. (1996) Direct intramuscular gene transfer of naked DNA encoding vascular endothelial growth factor augments collateral development and tissue perfusion. Circulation. 94, 3281–3290.PubMedGoogle Scholar
  16. 16.
    16. Takeshita, S., Isshiki, T., and Sato, T. (1996) Increased expression of direct gene transfer into skeletal muscles observed after acute ischemic injury in rats. Lab. Invest. 74, 1061–1065.PubMedGoogle Scholar
  17. 17.
    17. Orlowski, S., Belehradek, J., Jr., Paoletti, C., and Mir, L.M. (1988) Transient electropermeabilization of cells in culture. Increase of the cytotoxicity of anticancer drugs. Biochem. Pharmacol. 37, 4727–4733.CrossRefPubMedGoogle Scholar
  18. 18.
    18. Jaroszeski, M.J., Dang, V., Pottinger, C., Hickey, J., Gilbert, R., and Heller, R. (2000) Toxicity of anticancer agents mediated by electroporation in vitro. Anticancer Drugs. 11, 201–208.CrossRefPubMedGoogle Scholar
  19. 19.
    19. Gehl, J., Skovsgaard, T., and Mir, L.M. (1998) Enhancement of cytotoxicity by electropermeabilization: an improved method for screening drugs. Anticancer Drugs. 9, 319–325.CrossRefPubMedGoogle Scholar
  20. 20.
    20. Gothelf, A., Mir, L.M., and Gehl, J. (2003) Electrochemotherapy: results of cancer treatment using enhanced delivery of bleomycin by electroporation. Cancer Treat. Rev. 29, 371–387.CrossRefPubMedGoogle Scholar
  21. 21.
    21. Sersa, G., Cemazar, M., and Miklavcic, D. (1995) Antitumor effectiveness of electrochemotherapy with cis-diamminedichloroplatinum(II) in mice. Cancer Res. 55, 3450–3455.PubMedGoogle Scholar
  22. 22.
    22. Sersa, G., Cemazar, M., and Rudolf, Z. (2003) Electrochemotherapy: advantages and drawbacks in treatment of cancer patients. Cancer Ther. 1, 133–142.Google Scholar
  23. 23.
    23. Mir, L.M., Moller, P.H., Andre, F., and Gehl, J. (2005) Electric pulse-mediated gene delivery to various animal tissues. Adv. Genet. 54, 83–114.CrossRefPubMedGoogle Scholar

Copyright information

© Humana Press 2008

Authors and Affiliations

  • Julie Gehl
    • 1
  1. 1.Department of OncologyCopenhagen University Hospital at HerlevHerlev RingvejDenmark

Personalised recommendations